Inventor
Keiko Sujino
Inventor
Edmonton, CA
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds9%
C07HSugars9%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07BGeneral methods of organic chemistry5%
C12NMicroorganisms or enzymes4%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
PatentTitleYear
10,954,199Process methods for phosphatidylinositol 3-kinase inhibitors202110,730,879Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one202010,414,737Process methods for phosphatidylinositol 3-kinase inhibitors201910,196,419Processes and intermediates for preparing anti-HIV agents201910,059,677Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof201810,047,060Process methods for phosphatidylinositol 3-kinase inhibitors20189,783,567'Processes and intermediates for preparing anti-HIV agents'20179,567,337'Process methods for phosphatidylinositol 3-kinase inhibitors'20179,469,643'Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one'20169,296,779'Processes and intermediates for preparing anti-HIV agents'20169,221,758'Methods of synthesizing pharmaceutical salts of a factor Xa inhibitor'20158,987,437'Processes and intermediates for preparing anti-HIV Agents'20158,865,730'Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one'20148,524,907'Methods of synthesizing pharmaceutical salts of a factor Xa inhibitor'20136,528,274'Method for the production of sialylated oligosaccharides'20036,194,178'Method for the production of sialylated oligosaccharides'20015,811,540'5-O-pyrimidyl-2,3-dideoxy-1-thiofuranoside derivative, and production method and use thereof'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998Based in Kawagoe, JP· patent location history
2001–2003Patents assigned to SYNSORB BIOTECH INC (2)· patent assignee history
2001–2021Based in Edmonton, CA· patent location history
2013–2015Patents assigned to MILLENNIUM PHARM INC (2)· patent assignee history
2013–2015Patents assigned to SUJINO KEIKO (2)· patent assignee history
2014–2021Patents assigned to GILEAD CALISTOGA LLC (8)· patent assignee history
2015–2021Patents assigned to GILEAD SCIENCES INC (6)· patent assignee history
2015Based in Foster City, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD CALISTOGA LLC | 8 | 2014–2021 |
| GILEAD SCIENCES INC | 6 | 2015–2021 |
| MILLENNIUM PHARM INC | 2 | 2013–2015 |
| SUJINO KEIKOself | 2 | 2013–2015 |
| SYNSORB BIOTECH INC | 2 | 2001–2003 |
Locations
| Location | Patents | Span |
|---|---|---|
| Edmonton, CA | 15 | 2001–2021 |
| Foster City, California, US | 1 | 2015 |
| Kawagoe, JP | 1 | 1998 |